Shanzhi Gu

2PUBLICATIONS
41CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

Pageof 1